Bank of New York Mellon
FHTX icon

Bank of New York Mellon’s Foghorn Therapeutics FHTX Stock Holding History

Bank of New York Mellon’s Portfolio FHTX Stock Details FHTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$387K Sell
79,355
-204
-0.3% -$905 ﹤0.01% 3871
2026
Q1 		$380K Buy
79,559
+661
+0.8% +$3.63K ﹤0.01% 3726
2025
Q4 		$426K Sell
78,898
-1,579
-2% -$7.16K ﹤0.01% 3692
2025
Q3 		$394K Buy
80,477
+8,040
+11% +$42.6K ﹤0.01% 3732
2025
Q2 		$340K Buy
72,437
+14,126
+24% +$59K ﹤0.01% 3737
2025
Q1 		$213K Sell
58,311
-1
-0% -$5 ﹤0.01% 3866
2024
Q4 		$275K Buy
58,312
+1,965
+3% +$14.3K ﹤0.01% 3823
2024
Q3 		$525K Sell
56,347
-23,086
-29% -$167K ﹤0.01% 3493
2024
Q2 		$457K Buy
79,433
+18,664
+31% +$111K ﹤0.01% 3625
2024
Q1 		$408K Buy
60,769
+3,571
+6% +$19.8K ﹤0.01% 3648
2023
Q4 		$369K Sell
57,198
-13,534
-19% -$58.4K ﹤0.01% 3712
2023
Q3 		$354K Sell
70,732
-1,055
-1% -$8.13K ﹤0.01% 3734
2023
Q2 		$505K Buy
71,787
+755
+1% +$5.28K ﹤0.01% 3589
2023
Q1 		$440K Sell
71,032
-16
-0% -$105 ﹤0.01% 3549
2022
Q4 		$453K Buy
71,048
+4,811
+7% +$36.3K ﹤0.01% 3589
2022
Q3 		$569K Buy
66,237
+15,254
+30% +$196K ﹤0.01% 3508
2022
Q2 		$693K Sell
50,983
-10,130
-17% -$131K ﹤0.01% 3396
2022
Q1 		$931K Sell
61,113
-40,326
-40% -$553K ﹤0.01% 3361
2021
Q4 		$2.32M Buy
101,439
+48,321
+91% +$695K ﹤0.01% 2900
2021
Q3 		$740K Buy
53,118
+1,699
+3% +$18.8K ﹤0.01% 3576
2021
Q2 		$549K Buy
51,419
+31,979
+165% +$348K ﹤0.01% 3726
2021
Q1 		$256K Buy
19,440
+1,354
+7% +$22.2K ﹤0.01% 3968
2020
Q4 		$367K Buy
+18,086
New +$346K ﹤0.01% 3752

Other funds holding FHTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
SCM
SCS Capital Management Boston, Massachusetts $10.6B AUM 19.73% 1-Year Est. Return
PAP
Persistent Asset Partners Hong Kong $335M AUM 275.57% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Bank of New York Mellon's FHTX Position: Q2 2026 in Review

Bank of New York Mellon reduced its Foghorn Therapeutics (FHTX) stake by 0.26% in Q2 2026, selling an estimated $905 and leaving 79,355 shares worth $387K. The position accounts for ﹤0.01% of the portfolio, ranked #3871.

Bank of New York Mellon first reported a position in FHTX in Q4 2020 and has held it in 23 quarters since. The position peaked at $2.32M in Q4 2021. 33 funds tracked by Wall St. Rank hold FHTX as of Q2 2026.

  • Bank of New York Mellon held 79,355 shares of Foghorn Therapeutics worth $387K as of Q2 2026.
  • Bank of New York Mellon sold 204 Foghorn Therapeutics shares in Q2 2026, an estimated $905.
  • Foghorn Therapeutics made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #3871 holding.
  • Bank of New York Mellon first reported a position in Foghorn Therapeutics in Q4 2020 and has held it in 23 quarters since.
  • Bank of New York Mellon's Foghorn Therapeutics position peaked at $2.32M in Q4 2021.
  • 33 funds tracked by Wall St. Rank held Foghorn Therapeutics as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.